Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.00
Bid: 4.00
Ask: 6.00
Change: 0.00 (0.00%)
Spread: 2.00 (50.00%)
Open: 5.00
High: 5.00
Low: 5.00
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of General Meeting

18 Jun 2018 07:02

RNS Number : 6273R
Braveheart Investment Group plc
18 June 2018
 

18 June 2018

 

Braveheart Investment Group plc

("Braveheart", the "Company" or the "Group")

 

Notice of GM

Proposed Reduction of Share Capital

 

 

Braveheart Investment Group plc (AIM: BRH), the fund management and strategic investor group, announces that it proposes to carry out a capital reduction by cancelling the whole of its share premium account thereby enabling the Directors to consider the payment of dividends to its shareholders as a means of returning income to shareholders should the Directors consider it is appropriate to do so.

 

A General Meeting is being convened to be held on 19 July 2018 at 11.30 a.m. (or immediately following the conclusion or adjournment of the Annual General Meeting called at 11.00 a.m. on that date) at the offices of Edwin Coe, 2 Stone Buildings, Lincoln's Inn, London WC2A 3TH ("the General Meeting") in order to consider, and if thought fit, pass the resolution necessary to implement the proposal.

 

The Company's 2018 Annual Report and Accounts show its total liabilities as at 31 March 2018 as £1,434,382, and its retained earnings as at that date as £33,293. However, the retained earnings include unrealised profits of circa £270,000 and do not include contingent liabilities of £147,982. Consequently, the Company does not have any distributable profits and is unable to declare dividends.

 

At the same time, the Company's accounts show a sum of £1,567,615 standing to the credit of its share premium account. The share premium account is an undistributable reserve and, accordingly, the purposes for which a company can use the sums credited to this reserve are very limited. However, with the consent of its shareholders and the approval of the Court, a company may reduce or cancel its share premium account and the reserve arising on such a reduction of capital may be used in diminishing or extinguishing a deficit or maximising returns to shareholders.

 

The Company therefore proposes to cancel the whole of its share premium account in order to generate distributable reserves of approximately £1.295 million, which would enable the Company to pay dividends (should circumstances in the future make it desirable to do so) to the extent of the distributable reserves created but subject to the financial position of the Company and its prospects at the relevant time and any undertakings given to the Court for the protection of the Company's creditors at the date that the Capital reduction becomes effective.

 

The cancellation of the Company's share premium account will only take effect if sanctioned by the Shareholders at the General Meeting and confirmed by the Court and upon the appropriate documents being lodged with the Registrar of Companies.

 

An application to the Court will be made as soon as practicable after the passing of the required shareholder resolution and the procedure is expected to be completed within six to eight weeks following the passing of the required shareholder resolution.

 

The Directors have been advised that, having regard to the circumstances at the date of this document, the Court is expected to confirm the Capital Reduction. The Directors are not, however, able to guarantee the Court's confirmation of the Capital Reduction. It is important to note that the Capital Reduction will not take effect unless it is confirmed by the Court.

 

The Directors have also been advised that the Court may require that the Company give undertakings for the protection of the Company's creditors at the date that the Capital Reduction becomes effective.

 

As at 31 March 2018, the Company's liabilities (including contingent liabilities) amounted to a total of approximately £1,582,274, of which (i) £147,892 relates to contingent liabilities arising under the guarantees provided by the Company pursuant to section 479 of the Companies Act and (ii) the balance of £1,434,382 relates to debts owed by the Company. The majority of its creditors consist of subsidiaries of the Company, in respect of which there are debts of £1,371,373 and contingent liabilities of £105,841. The relevant subsidiaries of the Company have indicated that they will consent to the Capital Reduction to generate distributable reserves and agree not to seek repayment of the sums due to them until such time as the sums due to the balance of the creditors (the "Remaining Creditors") at the date on which the capital reduction takes effect (the "Effective Date") have been repaid in full. The Remaining Creditors at the Effective Date are due to be paid a total amount of approximately £63,000 and there are contingent liabilities to Remaining Creditors of approximately £42,000.

 

The Company will if required give an undertaking to the Court that the part of the distributable reserves created by the Capital Reduction equal to the sums due to the Remaining Creditors at the Effective Date will not be used for any other purposes without paying those Remaining Creditors the sums due to them on the Effective Date, except to the extent that the Remaining Creditors consent to those distributable reserves being used for other purposes.

 

A notice convening a General Meeting to consider and, if thought fit, pass the necessary resolution will be set out in a Circular which will be sent to shareholders shortly and will be available on the Company's website www.braveheartgroup.co.uk.

 

 

For further information:

 

Braveheart Investment Group plc +44 (0) 1738 587555

Trevor Brown, Chief Executive

 

Allenby Capital Limited (Nominated Adviser and Broker) +44 (0) 20 3328 5656

David Worlidge / Nicholas Chambers

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOGBLGDLSUBBGIU
Date   Source Headline
2nd Jun 20204:36 pmRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSOperational update on Kirkstall Limited
1st Jun 20207:00 amRNSFurther re Paraytec Limited
29th May 20205:00 pmRNSTotal Voting Rights
21st May 20207:00 amRNSHolding in Phasefocus increased and other matters
20th May 20202:05 pmRNSSecond Price Monitoring Extn
20th May 20202:00 pmRNSPrice Monitoring Extension
20th May 202011:05 amRNSSecond Price Monitoring Extn
20th May 202011:00 amRNSPrice Monitoring Extension
20th May 20209:34 amRNSHolding(s) in Company
19th May 202012:48 pmRNSHolding(s) in Company
11th May 20208:51 amRNSHolding(s) in Company
11th May 20207:01 amRNSHolding(s) in Company
11th May 20207:00 amRNSHolding(s) in Company
7th May 20206:15 pmRNSHolding(s) in Company
6th May 20207:00 amRNSUpdate in response to social media speculation
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:36 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSFurther re Kirkstall Limited
1st May 20207:00 amRNSFurther Placing to raise £350,000
29th Apr 20204:40 pmRNSSecond Price Monitoring Extn
29th Apr 20204:36 pmRNSPrice Monitoring Extension
29th Apr 20207:00 amRNSPlacing to raise £275,000
27th Apr 202011:05 amRNSSecond Price Monitoring Extn
27th Apr 202011:00 amRNSPrice Monitoring Extension
23rd Apr 20207:00 amRNSOperational update re certain investments
14th Apr 20207:00 amRNSOperational update on the Strategic Investments
3rd Mar 20207:00 amRNSOperational Update and Strategic Investments
30th Jan 20207:00 amRNSOperational update on Strategic Investments
12th Dec 20197:00 amRNSFurther investment in Pharm 2 Farm Limited
21st Nov 20197:00 amRNSOperational update on strategic investments
31st Oct 201910:55 amRNSHalf-year Report
28th Oct 20195:12 pmRNSFurther re buying remaining shares of Paraytec
19th Sep 20197:00 amRNSResults of customer trials by Pharm2Farm Limited
18th Sep 20197:00 amRNSDiscussions to buy remaining shares of Paraytec
29th Aug 201912:20 pmRNSResult of AGM
5th Aug 20197:00 amRNSPosting of annual accounts
1st Aug 20193:27 pmRNSREPLACEMENT: Final Results
1st Aug 20197:00 amRNSFinal Results
8th Jul 20197:00 amRNSInvestment in Pharm2Farm Limited
7th Jun 20197:00 amRNSUpdate to the Market
16th Apr 20197:00 amRNSDisposal of Viking Fund Managers Limited
12th Feb 201910:25 amRNSHolding(s) in Company
31st Jan 20195:17 pmRNSHolding(s) in Company
13th Dec 20187:00 amRNSFund Management Division Update
30th Oct 20187:00 amRNSInterim Results
18th Oct 201811:28 amRNSUpdate re Reduction of Share Capital
24th Sep 20189:00 amRNSConversion of Loan Notes in Paraytec Limited
4th Sep 20187:00 amRNSFurther re. Partial Disposal of Investment
21st Aug 20187:00 amRNSPartial Disposal of Investment in Gyrometric

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.